Uso de cookies Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continúa navegando, consideramos que acepta su uso. Puede obtener más información sobre nuestra: Política de cookies

The global fashion business journal

12 Dec 201818:15

Luxottica and Essilor complete merger process and create 15 billion euro giant

The new group will hold its fits board meeting on November 29, while company shares could start trading at Euronext Paris as soon as of tomorrow. Essilorluxottica will operate in 150 countries worldwide.

01 Oct 2018 — 18:00
MDS
Share
Save

Luxottica and Essilor complete merger process and create 15 billion euro giant

 

 

Luxottica and Essilor complete their merger. Twenty-one months after announcing their fusion, the eyewear group and the ophthalmic lens maker has finished the process, as shares of the newly born company could start trading at Euronext Paris as soon as of tomorrow.

 

Through its subsidiary Delfin, Luxottica will transfer its shares to Essilor, which will be renamed as Essilorluxottica. In October 11, as part of the merger process, the new company will submit to the Italian stock exchange the prospectus related to the mandatory public offer for the subscription of shares, according to Il Messanggero.

 

This way, the union between Luxottica, one of the biggest eyewear manufacturers worldwide with brands like Ray-Ban, and Essilor, focused on ophthalmic lens. The first board meeting of the group will take place on November 29.

 

 

 

 

Essilorluxottica will operate in 150 countries worldwide with a workforce of 140,000 employees. The group has revenues of more than 15 billion euros per year. The merger process was kick-started in January 2017, but its approval has been delayed for several reasons, among them an investigation by the European Commission to ensure that the new company didn’t violate competition rules.

 

Last March, Brussels approved the deal and, later on, Chinise antitrust bodies also enabled the merger, but with the condition that selling prices weren’t lower than manufacturing costs without a reason to justify this.

Advertising
Comment
Share
Participation rules

info@themds.com

 

Validation policy for comments: 

 
MDS does not perform prior verification for the publication of comments. However, to prevent anonymous comments from affecting the rights of third parties without the ability to reply, all comments require a valid email address, which won’t be visible or shared.
 
Enter your name and email address to be able to comment on this news: once you click on the link you will find within your verification email, your comment will be published.

0 comments — Be the first to comment
...